Company Filing History:
Years Active: 2021
Title: Sarah Ongley: Innovator in Recombinant Microcystin Production
Introduction
Sarah Ongley is a prominent inventor based in New South Wales, Australia. She has made significant contributions to the field of biotechnology, particularly in the production of microcystin. Her innovative work has led to the development of methods that enhance the efficiency of microcystin production through recombinant technology.
Latest Patents
Sarah Ongley holds a patent for her invention titled "Recombinant microcystin production." This invention relates to methods for producing microcystin and recombinant cells capable of producing it. The recombinant cells express exogenous microcystin synthase polypeptides under the control of an exogenous promoter, and they further express an exogenous phosphopantethienyl transferase (PPTase). The invention also encompasses the microcystin produced in recombinant cells by the methods described.
Career Highlights
Sarah Ongley is associated with Newsouth Innovations Pty Limited, where she applies her expertise in biotechnology. Her work has been instrumental in advancing the understanding and production of microcystin, which has implications for various applications in research and industry.
Collaborations
Sarah has collaborated with notable colleagues, including Brett A Neilan and Tianzhe Liu. These collaborations have fostered a productive environment for innovation and research in the field of biotechnology.
Conclusion
In summary, Sarah Ongley is a dedicated inventor whose work in recombinant microcystin production showcases her commitment to advancing biotechnology. Her contributions are paving the way for future innovations in this important field.